// App-Quantinova.ai

: Validation of a genomic classifier to predict adverse pathology in men diagnosed with low risk prostate cancer.

Researchers

Presenter

  • Hyung Lae Kim

Principal Investigators

  • Ping Li

  • Huei-Chung Huang

  • Samineh Deheshi

  • Beatrice Knudsen

  • Hatem Abou-Ouf

  • Lucia L.C. Lam

  • Jennifer Margrave

  • Marguerite Du Plessis

  • Elai Davicioni

  • Jeffrey J. Tosoian

  • Ashley Ross

  • John W. Davis

  • M. Eric Hyndman

  • Eric A. Klein

  • Tarek A. Bismar

Medical Centers

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • University of Calgary, Calgary, AB, Canada

  • Johns Hopkins Medicine, Baltimore, MD

  • 1.MD Anderson Cancer Center, Houston, TX

  • Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland, OH

Locations

  • United States

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved